On the afternoon of July 11, 2025, XH-02 injection, a proprietary mRNA drug developed by PUMCH, was successfully administered to the first adult patient with hypoparathyroidism (HP). XH-02 injection is the world's first mRNA drug for adult hypoparathyroidism, ...

A national multicenter trial — Methotrexate on Effusion-synovitis and Symptoms in Knee Osteoarthritis (MESKO) (MESKO trial) — examining the use of methotrexate for inflammatory knee osteoarthritis (OA) has been published in JAMA Internal Medicine. It was condu...

A cross-institutional research team led by Dr. Chen Youxin, Chief Physician of the Department of Ophthalmology at PUMCH, has successfully developed the AI-powered WARM system based on ultra-wide-field (UWF) fundus imaging and deep learning technology. This sys...

Recently, a study led by Professor Zhu Lan, Director of the Department of Obstetrics and Gynecology at PUMCH, investigating the effects of intravaginal oestrogen on pessary use in patients with pelvic organ prolapse (POP), was published online in the i...